CHARLES SCHWAB INVESTMENT MANAGEMENT INC - EDGE THERAPEUTICS INC ownership

EDGE THERAPEUTICS INC's ticker is EDGE and the CUSIP is 279870109. A total of 52 filers reported holding EDGE THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.8%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of EDGE THERAPEUTICS INC
ValueSharesWeighting
Q1 2018$106,000
-87.4%
89,503
-0.1%
0.00%
-100.0%
Q4 2017$840,000
-2.4%
89,594
+11.8%
0.00%0.0%
Q3 2017$861,000
+11.4%
80,170
+6.5%
0.00%0.0%
Q2 2017$773,000
+13.5%
75,279
+0.7%
0.00%0.0%
Q1 2017$681,000
-22.2%
74,747
+6.8%
0.00%0.0%
Q4 2016$875,000
+27.9%
69,959
+6.6%
0.00%0.0%
Q3 2016$684,000
+70.1%
65,647
+65.2%
0.00%0.0%
Q2 2016$402,000
+66.1%
39,726
+50.8%
0.00%
Q1 2016$242,000
-25.3%
26,348
+1.8%
0.00%
Q4 2015$324,00025,8890.00%
Other shareholders
EDGE THERAPEUTICS INC shareholders Q4 2016
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 2,344,868$24,058,00016.90%
VHCP Management II, LLC 1,933,582$19,839,0007.92%
ACUTA CAPITAL PARTNERS, LLC 1,504,612$15,437,0004.32%
Opaleye Management Inc. 130,000$1,334,0000.56%
SPHERA FUNDS MANAGEMENT LTD. 150,000$1,539,0000.26%
DAFNA Capital Management LLC 19,400$199,0000.14%
REGENTATLANTIC CAPITAL LLC 134,900$1,384,0000.13%
MARK SHEPTOFF FINANCIAL PLANNING, LLC 14,400$148,0000.10%
TFS CAPITAL LLC 20,080$206,0000.08%
EAGLE ASSET MANAGEMENT INC 901,359$9,247,0000.06%
View complete list of EDGE THERAPEUTICS INC shareholders